Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is characterized by an initial airway inflammatory insult that results in diffuse alveolar damage and the subsequent development of respiratory failure. Despite an incidence of ~200,000 cases/year in the United States and mortality rate approaching 40%, no effective therapy exists to treat ALI/ARDS. S-nitrosothiols (SNOs) are endogenously-produced, bioactive forms of nitric oxide that function to inhibit immune response pathways in the respiratory epithelium. Recently, we demonstrated that airway SNOs are acutely depleted in a mouse model of ALI and that treatment with inhaled ethyl nitrite (ENO), an S-nitrosylating agent, protects from the development of lung injury. However, the molecular targets of SNOs in the lung airway remain to be discerned. We hypothesize that proteomic signatures derived from analysis of airway lining fluid can be used to elucidate the SNO-regulated immune response pathways in ALI which underlie the pharmacological basis of ENO therapy. Accordingly, we propose to: 1. Characterize the effects of ENO treatment on the airway proteome in ALI and identify signaling pathways that are affected by SNO repletion;and 2. Identify BALF proteins that are modified by S- nitrosylation in ALI and determine the effects of S-nitrosylation on their inflammatory activities.. Completion of these specific aims should provide a fuller understanding of SNO-regulated pathways in the airways and will guide the further study of SNO-based therapy for the prevention and resolution of inflammatory lung injury.

Public Health Relevance

Ethyl nitrite (ENO), a gaseous S-nitrosylating agent, is protective in animal models of acute lung injury. We will determine the molecular targets of ENO therapy by quantifying gene and protein level changes, as well as protein S-nitrosylation, in the airways of ENO-treated mice

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Harabin, Andrea L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Figueiredo-Freitas, CĂ­cero; Dulce, Raul A; Foster, Matthew W et al. (2015) S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca2+)Sensitivity in Intact Cardiomyocytes. Antioxid Redox Signal 23:1017-34
Kelleher, Zachary T; Sha, Yonggang; Foster, Matthew W et al. (2014) Thioredoxin-mediated denitrosylation regulates cytokine-induced nuclear factor ?B (NF-?B) activation. J Biol Chem 289:3066-72
Foster, Matthew W; Thompson, J Will; Que, Loretta G et al. (2013) Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure. J Proteome Res 12:2194-205
Foster, Matthew W; Thompson, J Will; Forrester, Michael T et al. (2013) Proteomic analysis of the NOS2 interactome in human airway epithelial cells. Nitric Oxide 34:37-46
Thompson, J Will; Forrester, Michael T; Moseley, M Arthur et al. (2013) Solid-phase capture for the detection and relative quantification of S-nitrosoproteins by mass spectrometry. Methods 62:130-7
Foster, Matthew W (2012) Methodologies for the characterization, identification and quantification of S-nitrosylated proteins. Biochim Biophys Acta 1820:675-83
Foster, Matthew W; Yang, Zhonghui; Gooden, David M et al. (2012) Proteomic characterization of the cellular response to nitrosative stress mediated by s-nitrosoglutathione reductase inhibition. J Proteome Res 11:2480-91
Marshall, Harvey E; Foster, Matthew W (2012) S-nitrosylation of Ras in breast cancer. Breast Cancer Res 14:113